Empiric Treatment of Fever in Acute Leukaemia with Tobramycin–Cephalothin, and the Escape Clause Provision of Corticosteroids

References

• . Atkinson, K., Kay, H. E. M. & McElwain, T. J.: Septicemia in the neutropenic patient. Br Med J 3: 244, 1974.
   PubMedGoogle Scholar
• . Bartlett, J. G. & Finegold, S. M.: Anaerobic pleuropulmonary infections. Medicine (Baltimore) 51: 413, 1972.
   PubMed Web of Science ®Google Scholar
• . Bodey, G. P., Middleman, E., Umsawadi, T. & Rodriguez, V.: Infections in cancer patients—results with gentamicin sulfate therapy. Cancer 29: 1697, 1972.
   PubMed Web of Science ®Google Scholar
• . Bodey, G. P.: Infections in cancer patients. Cancer Treat Rev 2: 89, 1975.
   PubMed Web of Science ®Google Scholar
• . Burke, P. J., Braine, H. G., Rathbun, H. K. & Owens, A. H., Jr: The clinical significance and management of fever in acute myelocytic leukemia. Johns Hopkins Med J 139: 1, 1976.
   PubMedGoogle Scholar
• . Clarkson, B. D.: Acute myelocytic leukemia in adults. Cancer 30: 1572, 1972.
   PubMed Web of Science ®Google Scholar
• . Cohen, J. D. & Miale, T. D.: Tobramycin and cephalothin for treatment of suspected sepsis in neutropenic children with cancer. J Infect Dis 134: Suppl. S 175, 1976.
   Google Scholar
• . The EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14, 1978.
   PubMed Web of Science ®Google Scholar
• . Fanning, W. L., Gump, D. & Jick, H.: Gentamicin- and cephalothin-associated rises in blood urea nitrogen. Antimicrob Agents Chemother 10: 80, 1976.
   PubMedGoogle Scholar
• . Fillastre, J. P., Laumonier, R., Humber, G., Dubois, D., Metayer, J., Delpech, A., Leroy, J. & Robert, M.: Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J 2: 396, 1973.
   PubMed Web of Science ®Google Scholar
• . Greene, W. H., Moody, M., Schimpff, S., Young, V. M. & Wiernik, P. H.: Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med 79: 684, 1973.
   PubMedGoogle Scholar
• . Holmes, R. K., Minsnew, H., Gould, K. & Sanford, J. P.: Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics. Antimicrob Agents Chemother 6: 253, 1974.
   PubMedGoogle Scholar
• . Horikoshi, N., Valdivieso, M. & Bodey, G. P.: Clinical pharmacology of tobramycin. Am J Med Sci 266: 453, 1973.
   PubMed Web of Science ®Google Scholar
• . Israel, K. S., Welles, J. S. & Black, H. R.: Aspects of the pharmacology and toxicity of tobramycin in animals and humans. J Infect Dis 134: Suppl. S 97, 1976.
   Google Scholar
• . Kahlmeter, G., Hallberg, T. & Kamme, C.: Gentamicin and tobramycin in patients with serious infections. II. Nephrotoxicity. J Antimicrob Chemother 4: Suppl. A S 47, 1978.
   PubMed Web of Science ®Google Scholar
• . Klastersky, J., Hensgens, C. & Debusscher, L.: Empiric therapy for cancer patients: comparative study of ticarcillin–tobramycin, ticarcillin–cephalothin and cephalothin–tobramycin. Antimicrob Agents Chemother 7: 640, 1975.
   PubMedGoogle Scholar
• . Klastersky, J.: The use of synergistic combinations of antibiotics in patients with hematological diseases. Clin Haematol 5: 361, 1976.
   PubMedGoogle Scholar
• . Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Greene, W. H., Schimpff, S. C., Calia, P. M. & Hornick, R. B.: Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 6: 442, 1974.
   Google Scholar
• . Lehmann, W., Häusler, R. & Waldvogel, F. A.: A clinical study on the ototoxic effects of tobramycin. Arch Otorhinolaryngol (NY) 212: 203, 1976.
   PubMedGoogle Scholar
• . Levine, A. S., Schimpff, S. C., Graw, R. G., Jr & Young, R. C.: Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol 11: 141, 1974.
   PubMed Web of Science ®Google Scholar
• . Mørk Hansen, M. & Kaaber, K.: Nephrotoxicity in combined cephalothin and gentamicin therapy. Acta Med Scand 201: 463, 1977.
   PubMedGoogle Scholar
• . Neu, H. C.: Tobramycin: An overview. J Infect Dis 134: Suppl. S 3, 1976.
   Web of Science ®Google Scholar
• . Neu, H. C. & Bendush, C. L.: Ototoxicity of tobramycin: a clinical overview. J Infect Dis 134: Suppl. S 206, 1976.
   Web of Science ®Google Scholar
• . Palmblad, J. & Wretlind, B.: Fever and bacterial infections in acute leukemia. Opusc Med 21: 20, 1976.
   Google Scholar
• . Reynolds, A. V., Hamilton-Miller, J. M. T. & Brumfitt, W.: Newer aminoglycosides—amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamycin. Br Med J 3: 778, 1974.
   PubMedGoogle Scholar
• . Rodriguez, V. & Bodey, G. P.: Antibacterial therapy—special considerations in neutropenic patients. Clin Haematol 5: 347, 1976.
   PubMedGoogle Scholar
• . Sickles, E. A., Young, V. M., Greene, W. H. & Wiernik, P. H.: Pneumonia in acute leukemia. Ann Intern Med 79: 528, 1973.
   PubMed Web of Science ®Google Scholar
• . Tobias, J. S., Whitehouse, J. M. & Wrigley, P. F. M.: Severe renal dysfunction after tobramycin/cephalothin therapy. Lancet 1: 425, 1976.
   PubMedGoogle Scholar
• . Valdivieso, M., Horikoshi, N., Rodriguez, V. & Bodey, G. P.: Therapeutic trials with tobramycin. Am J Med Sci 268: 149, 1974.
   PubMed Web of Science ®Google Scholar
• . Vincent, P. C., Jennis, F., Hilmer, R. & Fabre, S.: Tobramycin and cephalothin sodium in treatment of infected patients with acute leukemia. J Infect Dis 134: Suppl. S 178, 1976.
   Google Scholar
• . Wilson, P. & Ramsden, R. T.: Immediate effect of tobramycin on human cochlea and correlation with serum tobramycin levels. Br Med J 1: 259, 1977.
   PubMedGoogle Scholar